DNAiTECH
Portable, low‑cost molecular diagnostics using LAMP‑CRISPR on paper microfluidics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Portable, low‑cost molecular diagnostics using LAMP‑CRISPR on paper microfluidics.
Infectious DiseasesAgricultureEnvironmental
Technology Platform
Isothermal nucleic‑acid amplification (LAMP) combined with CRISPR detection on paper‑based microfluidics, paired with a portable sample‑prep system (S‑TECH).
Opportunities
Low‑cost, paper‑based POC diagnostics can rapidly expand in low‑resource healthcare settings, veterinary markets, and agricultural pathogen surveillance, especially as global demand for ASSURED‑compliant tests grows.
Risk Factors
Regulatory approval timelines, scaling manufacturing of paper cartridges, and competition from established POC platforms could delay commercial rollout.
Competitive Landscape
DNAiTECH competes with companies like Abbott, Cepheid, and Thermo Fisher, but differentiates through its ultra‑low‑cost paper microfluidics, battery‑powered operation, and integrated CRISPR specificity.